Child Health Conference

This unique conference focused on new therapeutic and technological approaches for treating rare diseases in early child development

08:30

GATHERING & REGISTRATION

09:00

GREETINGS

Prof. Joseph Klafter, President, TAU

Prof. Yoav Henis, Vice President, TAU

Prof. Ehud Gazit, Head, BLAVATNIK CENTER for Drug Discovery

Prof. Inna Slutsky, Sagol School of Neuroscience

09:40-10:20

KEYNOTE SESSION

Chair: Prof. Inna Slutsky, TAU

Prof. Søren W. Gersting, Pediatric Research at Kinder-UKE, University Medical Center Hamburg Eppendorf
Pharmacological chaperones for the treatment of rare diseases; The Kinder-UKE screening platform

10:20-11:20

SESSION 1

Chair: Dr. Moran Rubinstein, TAU

Dr. Ilan Dienstein, Ben Gurion University
From sleep recordings to motion capture: developing objective quantitative measures of symptom severity in children with autism

Prof. Hanoch Senderowitz, Bar Ilan University
Combating Cystic Fibrosis: Computational Studies on CFTR

Dr. Evan Elliot, Bar Ilan University
Microbiome-Epigenetic-Genetic interaction in the development of autism spectrum disorder

11:20-11:40

COFFEE BREAK

11:40-13:00

SESSION 2

Chair: Dr. Lior Mayo, TAU

Prof. Dani Offen, Rabin Medical Center-Beilinson Campus
Stem Cells in the Treatment of Autism

Dr. Boaz Barak, TAU
Altered myelination as a novel pathophysiological approach in Williams syndrome

Dr. Yair Anikster, Sheba Medical Center
Novel metabolic pathways: Paving the path towards targeted treatment

Shiri Soudry, MD Rambam Health Care Campus
Visual loss in children: In with the new

13:00-14:00

LUNCH BREAK

14:00-14:30

KEYNOTE SESSION

Dr. Alessandro Prigione, Max-Delbrück-Centrum for Molecular Medicine
Modeling and drug discovery of Leigh syndrome using patient-derived neural cells

14:30-15:45

SESSION 3

Chair: Prof. Ditza Antebi-Zachor, TAU and Assaf Harofe Medical Center

Dr. Gali Havazelet-Heimer, Sheba Medical Center
Angelman syndrome – from the clinic to the search for novel therapeutic strategies

Prof. Illana Gozes, TAU
Activity-dependent neuroprotective protein (ADNP) deficiency models synaptic and developmental phenotypes of autism-like syndrome: Toward innovative drug development

Prof. David (Dedi) Meiri, Technion
Behind the smokescreen of medical cannabis

Dr. Tzipi Horowitz-Kraus, Technion

Neuroplasticity in developmental disorders: the specific case of dyslexia